AntoineBDouaihyMD

Addiction

Professor of Psychiatry and Medicine at University of Pittsburgh School of Medicine Senior Academic Director of Addiction Medicine Services and Addiction Psychiatry Fellowship at Western Psychiatric Hospital

Join to view full profile

Dr. Douaihy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Douaihy's full profile

Already have an account?

Office
3811 O'Hara Street
Pittsburgh, PA 15213
Phone+1 412-624-1000

Education & Training

SUNY Upstate Medical UniversityResidency, Psychiatry, 1992 - 1996
St Joseph's University Medical SchoolClass of 1990

Certifications & Licensure

CA State Medical License 1999 - Present
PA State Medical License 1997 - 2024
NY State Medical License 1996 - 1999
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

52 citations
Double-Blind Placebo-Controlled Trial of Fluoxetine in Adolescents with Comorbid Major Depression and an Alcohol Use Disorder
Jack R. Cornelius, Oscar G. Bukstein, D. Scott Wood, Levent Kirisci, Antoine Douaihy
Addictive Behaviors. 2009-10-01
73 citations
Double-Blind Fluoxetine Trial in Comorbid MDD-CUD Youth and Young Adults
Jack R. Cornelius, Oscar G. Bukstein, Antoine Douaihy, Duncan B. Clark, Tammy Chung
Drug and Alcohol Dependence. 2010-11-01
23 citations
Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.
Ihsan M. Salloum, Antoine Douaihy, Jack R. Cornelius, Levent Kirisci, Thomas M. Kelly
Addictive Behaviors. 2007-02-01

Journal Articles

American Psychiatric Association Publishing
Antoine Douaihy, David Brent, Tina Goldstein, Aleksandra A Foxwell, National Institutes of Health

Press Mentions

How Cannabis Users Can Watch Out for Drug Interaction RisksApril 24th, 2022
Foundation for Opioid Response Efforts (FORE) Announces Grants Totaling $1.3 Million to Assess Impact of COVID-19 on Opioid Use Disorder Treatment and EquityMarch 16th, 2021
AA, Other 12-Step Programs More Effective Than Talk…March 13th, 2020
Join now to see all